http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FI-44237-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0f72c66096c79f62800a395826ee550 |
| filingDate | 1964-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1971-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd078ac4044ed5b30111f491c42dfad5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb2dff16acd327e89d1d0d572ed7e988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_addd886ebb40377c272042fd1ca55304 |
| publicationDate | 1971-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FI-44237-C |
| titleOfInvention | For example, 1,2-diphenyl-3,5-dioxo-4- (3'-oxobutyl) -pyrazolidine is preferred for therapeutic use. |
| priorityDate | 1964-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591226 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3824 |
Total number of triples: 13.